Skip to main content


08.05.2020 Press releases

MedImpact earns URAC accreditation, 100% score across all pharmacy benefit management quality standards.

Perfect score highlights company’s commitment to clinical, operational excellence, and customer service

San Diego, CA (05/08/2020) -- MedImpact, the health solutions and pharmacy benefit management company, today announced that it earned URAC accreditation for pharmacy benefit management (PBM), scoring 100% across all six modules of quality standards.


“We are unwavering in our commitment to healthcare quality and hold ourselves to the highest standards.”


"While we are proud to achieve a perfect score across all of URAC’s six PBM quality measures, we have a culture of continuous improvement and, when it comes to quality and customer service, we are never satisfied," continued Brown.

URAC is a non-profit that promotes health care quality through the accreditation of organizations involved in medical care. URAC benchmarks organizations against nationally recognized standards and supports improvements and innovation in healthcare management and delivery.

The URAC accreditation for PBM covers six quality modules: drug utilization management, customer service/disclosures, pharmacy network distribution, pharmacy and therapeutics and formulary development, core business practices, and performance measures.

“URAC accreditation shows that MedImpact is a pharmacy benefit management organization able to adhere to standards that cover important aspects of care such as claims processing, developing proper drug formulary, and consumer access,” said URAC President and CEO Shawn Griffin, M.D. “Quality policies and procedures are paramount as the price and complexity of medications rise. MedImpact chose to demonstrate their performance through URAC’s independent accreditation of their services.”

Learn more about the URAC accreditation for pharmacy benefit management.


About MedImpact
MedImpact is the PBM that puts clients and consumers first. For 30 years, it has had a single mission: To make pharmacy benefits affordable and understandable. Today, MedImpact’s team and technology serve many large employers and plans, and more than 55 million consumers in the US and around the world. Learn more at or follow us on Twitter @MedImpact

About URAC
Founded in 1990, URAC is the independent leader in promoting healthcare quality through leadership, accreditation, measurement and innovation. URAC is a nonprofit organization using evidence-based measures and developing standards through inclusive engagement with a range of stakeholders committed to improving the quality of healthcare. Our portfolio of accreditation and certification programs span the healthcare industry, addressing healthcare management, healthcare operations, health plans, pharmacies, telehealth providers, physician practices, and more. URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability.

Read on.
Keep up to date on the latest in the industry.
Client news
Dispelling the myth: generics are not always low cost.
When we hear the terms “generic” or “off-brand,” we typically think that the product would be a significantly cheaper alternative than the name brand. Well, when it comes to generic drugs, that’s not always in the case. Here are five facts plan sponsors should know:
Client news
FDA approves first and only treatment for common mutation in advanced breast cancer.
The FDA approved a new drug that is a potential game changer for advanced breast cancer patients. Piqray (alpelisib) gained approval on May 24 for treatment of postmenopausal women and men with one of the most commonly mutated genes in advanced or metastatic breast cancer.
Client news
Can you put a price on life?
FDA approves world’s most expensive drug with broad indication to treat rare childhood neuromuscular disease.

Ready for clarity from your PBM?